Marinomed Biotech AG | Finanzwire

Basculer en Français

8302	Companies
115125	Keywords
55448	Articles
62531	Press releases

Home
Companies
Marinomed Biotech AG

BRIEF

published on 04/25/2024 at 07:50, 6 months 26 days ago

Marinomed Biotech AG Announces New R&D Collaboration with Aché Laboratórios

Marinomed Biotech Aché Laboratórios Pharmaceutical R&D Marinosolv Technology Latin America Pharmaceutical Market
PRESS RELEASE

published on 04/25/2024 at 07:45, 6 months 26 days ago

Marinomed Biotech AG enters Solv4U R&D collaboration with Brazilian pharmaceutical company Aché Laboratórios
Marinomed Biotech AG announces R&D collaboration with Aché Laboratórios, applying Marinosolv technology to develop pharmaceutical products for Latin America

Pharmaceutical Products Marinomed Biotech AG Aché Laboratórios Marinosolv Technology R&D Collaboration
BRIEF

published on 04/16/2024 at 07:50, 7 months 5 days ago

Marinomed Biotech AG Reports Financial Results for 2023 and Development Progress

Biotechnology Marinomed Biotech AG Carragelose Financial Results 2023 Marinosolv
PRESS RELEASE

published on 04/16/2024 at 07:45, 7 months 5 days ago

Marinomed Biotech AG announces results for the 2023 financial year and reports progress with Marinosolv and Carragelose assets
Marinomed Biotech AG announces 2023 financial year results, highlighting progress with Marinosolv and Carragelose assets. Focus on achieving operating profitability and commercialization

2023 Financial Year Operating Profitability Marinomed Biotech AG Marinosolv Carragelose Assets
BRIEF

published on 04/11/2024 at 07:50, 7 months 10 days ago

Marinomed Biotech AG Announces Dual Market Expansion for Carragelose Products

Carragelose Market Expansion Marinomed Biotech Nasal Spray Allergen-blocking
PRESS RELEASE

published on 04/11/2024 at 07:45, 7 months 10 days ago

Marinomed Biotech AG: Launch of new allergen-blocking Carragelose product in Austria and market entry in Mexico
Marinomed Biotech AG expands Carragelose product portfolio with new launches in Austria and Mexico, targeting new indications and key markets

Mexico Marinomed Biotech AG Carragelose Allergen-blocking Austria
BRIEF

published on 03/28/2024 at 07:50, 7 months 24 days ago

Marinomed Biotech AG Secures Loan Repayment Deferral with European Investment Bank

Marinomed Biotech AG European Investment Bank Loan Repayment Deferral Marinosolv Platform Carragelose Business Expansion
PRESS RELEASE

published on 03/28/2024 at 07:45, 7 months 24 days ago

Marinomed Biotech AG announces agreement with European Investment Bank (EIB) to defer repayments of the 2019 venture loan for 18 months
Marinomed Biotech AG announces agreement with European Investment Bank (EIB) to defer repayments of the 2019 venture loan for 18 months

Marinomed Biotech AG European Investment Bank Deferral Agreement Marinosolv Platform Venture Loan
BRIEF

published on 03/26/2024 at 07:50, 7 months 26 days ago

Marinomed Biotech AG Expands Carragelose Distribution in Gulf Region and Eastern Europe

Carragelose Marinomed GAIA Healthcare VitaPlus Kft Pharmaceutical Distribution
PRESS RELEASE

published on 03/26/2024 at 07:45, 7 months 26 days ago

Marinomed Biotech AG enters new Carragelose distribution partnerships for Gulf region and Eastern Europe
Marinomed Biotech AG partners with GAIA Healthcare FZ LLC and VitaPlus Kft. to distribute Carragelose nasal sprays in Gulf region and Eastern Europe, expanding market reach

Marinomed Biotech AG Carragelose Distribution Partnerships GAIA Healthcare FZ LLC VitaPlus Kft.

Accesswire

Published on 11/22/2024 at 00:00, 20 minutes ago

Gratomic Announces Company and Operational Update
Published on 11/21/2024 at 22:05, 2 hours 15 minutes ago

Protagonist Announces Nomination of PN-881, a Potential Best-in-Class Oral Peptide IL-17 Antagonist Development Candidate
Published on 11/21/2024 at 21:50, 2 hours 30 minutes ago

Seventy Ninth Resources Announces Successful First Reconnaissance at McKellar Copper-Zinc and Enable Gold Projects
Published on 11/21/2024 at 20:15, 4 hours 5 minutes ago

Woodland Park Zoo Awarded Transformative Grant to Advance Empathy for Animals
Published on 11/21/2024 at 20:10, 4 hours 10 minutes ago

For Us TV Productions, a Portfolio Company of Belle Bonica Luxe Corp., Invites BIPOC Filmmakers and Producers to Join Its Inclusive Streaming Platform

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 19:01, 5 hours 19 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/21/2024 at 18:36, 5 hours 44 minutes ago

Original-Research: Beaconsmind AG (von First Berlin Equity Research GmbH): BUY
Published on 11/21/2024 at 17:58, 6 hours 22 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/21/2024 at 17:51, 6 hours 28 minutes ago

LIGHTON announces highly successful IPO on Euronext Growth Paris.
Published on 11/21/2024 at 17:51, 6 hours 29 minutes ago

2CRSi SA: 2CRSi supplies Exaion, a subsidiary of the EDF Group, with high-performance immersion servers in North America.

Les Echos

Published on 11/21/2024 at 06:58, 17 hours 22 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 1 day 5 hours ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 1 day 6 hours ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 1 day 6 hours ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 16 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE